On Tuesday, June 17, Greenberg Traurig will host an in-person luncheon seminar titled “Building Your IP Strategy to Succeed in the U.S.” Tailored specifically for life sciences companies aiming to enter or expand their presence in the U.S. market, the event promises to offer valuable insights from seasoned industry professionals. Attendees will gain practical guidance on crafting a robust intellectual property strategy—one that can help close funding rounds, secure competitive market share, and lay the groundwork for a successful exit, whether through mergers and acquisitions, initial public offerings, or licensing agreements. The seminar will explore essential IP tools, including patents, trademarks, and trade secrets, and how they can be leveraged as strategic assets in a highly competitive landscape.
The session will be led by a distinguished panel of speakers:
• Koichiro Ohashi, Co-Chair of Greenberg Traurig’s Japan Practice
• David Dykeman, Co-Chair of the firm’s Global Life Sciences & MedTech Group
• Melissa Hunter-Ensor, Ph.D., Co-Chair of the Global Patents and Innovation Strategies Group
Register Here.